The management of Ergomed (AIM:ERGO.L), which offers clinical trials and pharmacovigilance services to pharmaceutical companies, while also co-developing a product portfolio of therapies, would like to invite you to a presentation of their interim results.
Dr Dan Weng, Chief Executive Officer, and Stephen Stamp, Chief Financial Officer, will give a presentation lasting approximately 30 mins and there will then be an opportunity for Q&A. If you would like to join please register now:
After registering, you will receive a confirmation email containing information about joining the webinar.
If you would like to submit any questions for management ahead of the meeting please send them to hannah@equitydevelopment.co.uk
